Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced a distribution agreement with PrimeTech Co., Ltd., a leading distributor of life science technologies in Japan. The partnership will bring Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.

Japan represents one of the world’s most advanced life science ecosystems, with strong investment in genomics, biomarker discovery, and translational research. Through this collaboration, PrimeTech will distribute Epigenica’s EpiFinder kits and support local researchers in adopting the technology for epigenetic analysis and biomarker discovery.

“Japan is a highly innovative market with world leading research institutions and strong interest in advanced omics technologies,” said Mohamad Takwa, CEO and co-founder of Epigenica. “We are delighted to partner with PrimeTech to make EpiFinder more accessible to researchers in Japan and support new discoveries in areas such as cancer biology, aging research, and precision medicine.”

PrimeTech has extensive experience supporting life science researchers and introducing innovative technologies to the Japanese market.

“We are very pleased to collaborate with Epigenica and introduce the EpiFinder technology to researchers in Japan,” said Ryosuke Ogihara, CEO of PrimeTech. “The ability to generate epigenetic information at the scale that EpiFinder offers opens exciting opportunities for biomarker discovery and translational research.”

Epigenica’s EpiFinder platform enables high throughput epigenetic profiling across different cell types and tissues, as well as the detection of epigenetic signals in blood through circulating nucleosomes. This provides researchers with a powerful tool to study gene regulation and discover novel epigenetic biomarkers.

The agreement represents an important step in Epigenica’s international commercialization strategy and further expands access to its technologies in key research markets.

About Epigenica

Epigenica AB is a Swedish biotechnology company developing innovative tools for epigenetic analysis. Its EpiFinder platform enables researchers to perform high quality epigenomic profiling at an unprecedented scale.

About PrimeTech

PrimeTech Co., Ltd. is a Japanese distributor of advanced life science technologies, supporting academic institutions, biotechnology companies, and pharmaceutical organizations across Japan.